Can age-distribution be an indicator of the goodness of COVID-19 testing?
View ORCID ProfileAmirhoshang Hoseinpour Dehkordi, Reza Nemati, Pouya Tavousi
doi: https://doi.org/10.1101/2020.12.21.20248690
Amirhoshang Hoseinpour Dehkordi
1School of Computer Science, Institute for Research in Fundamental Sciences, Tehran, Iran
Reza Nemati
2Biotherapeutic and Medicinal Sciences, Biogen, Cambridge, MA, USA
Pouya Tavousi
3UConn Tech Park, University of Connecticut, Storrs, CT, USA
Data Availability
All data are publicly available.
Posted December 28, 2020.
Can age-distribution be an indicator of the goodness of COVID-19 testing?
Amirhoshang Hoseinpour Dehkordi, Reza Nemati, Pouya Tavousi
medRxiv 2020.12.21.20248690; doi: https://doi.org/10.1101/2020.12.21.20248690
Subject Area
Subject Areas
- Addiction Medicine (381)
- Allergy and Immunology (699)
- Anesthesia (189)
- Cardiovascular Medicine (2832)
- Dermatology (242)
- Emergency Medicine (427)
- Epidemiology (12531)
- Forensic Medicine (10)
- Gastroenterology (799)
- Genetic and Genomic Medicine (4408)
- Geriatric Medicine (400)
- Health Economics (712)
- Health Informatics (2837)
- Health Policy (1045)
- Hematology (373)
- HIV/AIDS (893)
- Medical Education (412)
- Medical Ethics (114)
- Nephrology (460)
- Neurology (4167)
- Nursing (220)
- Nutrition (615)
- Oncology (2194)
- Ophthalmology (623)
- Orthopedics (254)
- Otolaryngology (316)
- Pain Medicine (265)
- Palliative Medicine (81)
- Pathology (485)
- Pediatrics (1169)
- Primary Care Research (481)
- Public and Global Health (6752)
- Radiology and Imaging (1484)
- Respiratory Medicine (897)
- Rheumatology (430)
- Sports Medicine (365)
- Surgery (471)
- Toxicology (57)
- Transplantation (200)
- Urology (173)